China's largest poultry vaccine manufacturer will use a novel gene transfer technology developed inFinland to research and develop a new vaccine for HPAI. QYH Biotech Company will also use FIT Biotech's novel vector...
详细信息
China's largest poultry vaccine manufacturer will use a novel gene transfer technology developed inFinland to research and develop a new vaccine for HPAI. QYH Biotech Company will also use FIT Biotech's novel vector technology to develop otheranimal dna vaccines, according to a joint press release by both companies. QYH is based in Beijing and has four plants in China. FIT Biotech, based in Tampere, Finland, developed a patented gene transportation unit (GTU) focusing on gene therapy and dna vaccines.
暂无评论